FDA Issues Ketek Public Health Advisory Regarding Liver Toxicity
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is evaluating three cases of severe hepatotoxicity, including one death, to determine if a labeling change is necessary for Sanofi-Aventis' antibiotic.